Recent advances in the management of Duchenne muscular dystrophy

  1. Lookup NU author(s)
  2. Dr Eugen-Matthias Strehle
  3. Professor Volker Straub
Author(s)Strehle EM, Straub V
Publication type Review
JournalArchives of Disease in Childhood
ISSN (print)0003-9888
ISSN (electronic)1468-2044
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Duchenne muscular dystrophy (DMD) is the commonest inherited neuromuscular disorder of childhood and mainly affects males. Over the course of the last century the average life expectancy of these patients has doubled and now stands at ~25 years. This progress has been made possible through advances in the diagnosis, treatment and long-term care of DMD patients. Basic and clinical research, national and international scientific networks, and parent and patient support groups have all contributed to achieving this goal. The advent of molecular genetic therapies and personalised medicine has opened up new avenues and raised hopes that one day a cure for this debilitating orphan disease will be found. The main purpose of this short review is to enable paediatricians to have informed discussions with parents of DMD boys about recent scientific advances affecting their child’s clinical care.
PubMed id26153505
Actions    Link to this publication